This information was published on 2025-07-01T00:11:02 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2518060 |
| (220) |
30 Jan 2025
|
| (511) (510) |
Class 5
Therapeutic drugs (medical); therapeutic agents (medical); therapeutic creams (medical); therapeutic biological products (medical); chemical products for therapeutical use; nutraceutical preparations for therapeutic or medical purposes; pharmaceutical preparations; pharmaceutical preparations for veterinary use; veterinary preparations; pharmaceutical preparations for oral use; throat sprays (medicated); mouth sprays for medical use; sedatives; pharmaceutical and medicinal preparations and substances Class 42 Scientific research for medical purposes; clinical trials; conducting clinical trials; medical research; scientific research; drug development; drug development services; pharmaceutical research and development; pharmaceutical research; research and development of pharmaceuticals and vaccines; laboratory services (scientific research or analysis); management of scientific research projects; preparation of reports relating to scientific and medical research; research in the field of cell and gene therapy; advisory, consultancy and information services related to the foregoing |
| (540) | Arovella |
| (550) | Word |
| (730) |
Arovella Therapeutics Limited
ACN/ABN 090987250 |
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.